MDMA will be approved to aid therapy for PTSD suffers

MDMA will be approved to aid therapy for PTSD suffers by 2021: research group

For the first time in decades, Canadian researchers are probing the potential of a psychedelic drug – ecstasy – for use in psychotherapy in a clinical trial approved by Health Canada. The Multidisciplinary Association for Psychedelic Studies (MAPS), is investigating the use of MDMA, the pure form of the party drug ecstasy, to assist…